Top compounds associated with response to RP11-321N4.5


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.18 3e-09
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.16 1e-07
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA LE-135 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA FK866 CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-06
Download CSV